Medical Materiel/Medical Biological Defense Equipment - Eng Dev
Abstract
This Program Element (PE) funds advanced development of medical materiel within the System Demonstration and Low Rate Initial Production portions of the acquisition life cycle using 6.5 (System Development and Demonstration) funding. It supports products successfully developed in the Systems Integration portion of the Systems Development and Demonstration phases through completion of the Milestone C Decision Review. Commercially-off-the-shelf (COTS) medical products are also tested and evaluated for military use, when available. This PE primarily includes pivotal (conclusive) human clinical trials necessary for licensure by the Food and Drug Administration (FDA). Project 812 funds military relevant human immunodeficiency virus (HIV) medical countermeasures. These funds provide for engineering and manufacturing development of candidate vaccines and drugs to permit large-scale field testing. Development focused on military unique needs effecting manning, mobilization, and deployment. Products from this project will normally transition to Department of Defense (DoD) Health Programs or Other Procurement, Army (OPA) Funds. Project 832 funds the engineering and manufacturing development of medical products for enhanced combat casualty care and follow-on care, including rehabilitation. Mature COTS medical products are also evaluated for military use. Consideration will also be given to reduce the medical sustainment footprint through smaller weight and cube volume, or equipment independence from supporting materiel. Products from this project will normally transition to OPA Funds. Project 849 funds development of candidate medical countermeasures for military relevant infectious diseases. These products fall in four major areas: vaccines, drugs, diagnostic kits/devices, and insect control measures to limit exposure and disease transmission. FDA approval is a mandatory obligation for all military products placed into the hands of medical providers or service members for human use. Products from this project will normally transition to DoD Health Programs or OPA funds. Project VS8 program receives products that transition from VS7 and funds effort to complete research and development for the medical evacuation (MEDEVAC) Mission Essential Packages (MEPs) to support 256 Medical Evacuation legacy helicopters. The Army's force design increased the number of air frames in the force from 12 to 15 aircraft for 37 MEDEVAC companies to better meet operational needs. These Projects are managed by United States (U.S.) Army Medical Materiel Development Activity (USAMMDA) and U.S. Army Medical Materiel Agency (USAMMA) of the U.S. Army Medical Research and Materiel Command.
Document Details
- Document Type
- R2 Budgetary Justification
- Publication Date
- Oct 01, 2018
- Source ID
- 0604807A_5_2040_PB_2018
- Change Summary Explanation
- Service Agency Name
- Army
Entities
Organizations
- United States Army
Related Documents
- Child Project: Mil HIV Vac&Drug Dev
- Child Accomplishment: Military HIV Vaccine and Drug Development
- Child Project: Field Medical Systems Engineering Development
- Child Accomplishment: Field Medical Systems Engineering Development PM Medical Devices
- Child Accomplishment: Field Medical Systems Engineering Development PM Pharmaceuticals
- Child Accomplishment: Field Medical Systems Engineering Development PM Integrated Clinical Systems (ICS)
- Child Accomplishment: Field Medical Systems Engineering Development PM Medical Support Systems
- Child Accomplishment: Field Medical Systems Engineering Development -PM Neurotrauma & Psychological Health
- Child Cost Item: 71defe434988ec94dbbbe37e07070671
- Child Cost Item: 5550ce343a4cfc92135aa421915b940f
- Child Cost Item: 35aac8d5a082fcb61ee54f73135ccf50
- Child Cost Item: df7f1c32051aa8d3611d69e22387d00d
- Child Cost Item: 81df5341d0850f2401a10a8f5312223b
- Child Cost Item: a2bdac2b9bc843f60907640504b2b225
- Child Cost Item: 107bcdb64447296be75d80d2cb5cb8d5
- Child Cost Item: 9599dd05af415e8a9370556ceaaa52f3
- Child Cost Item: 0dc68f30d20437c31a1c2ce24e9010d1
- Child Cost Item: 1cf9271ea861a2c48f6d5cae1b82f9c1
- Child Cost Item: 9a70b22b3fff2ccfb1279fb7a17046a5
- Child Cost Item: 20889fea682764d6b9b35649a5a3c6e7
- Child Cost Item: 6c9b4c6e83d5da7eff65a89784ede861
- Child Cost Item: f3f76b944ec2d4ddb8438f94b650ec23
- Child Cost Item: 56de8ed3006c1fd81d3fd49523315ad1
- Child Cost Item: 2226d2c4e244775c5737ffdf0d3741ec
- Child Cost Item: cc65c314824dcc50faa3a788884fc769
- Child Cost Item: 34bd3af11080c69445755fbb398be336
- Child Cost Item: de0aef88057610ba863e519cc179dbe4
- Child Cost Item: 5a3c3759b6f2f2732c5b7cd364acfe72
- Child Cost Item: fd426514998a27e60ab9a5ec9826d04e
- Child Cost Item: 7c73dcb5b68e46c05562fe3505470c8c
- Child Cost Item: b759548efee9ed81f97032cd331330e6
- Child Project: Infec Dis Drug/Vacc Ed
- Child Accomplishment: Infectious Disease Drug and Vaccine Engineering Development
- Child Cost Item: b209a0c73636c0ed6382bbd84a23c5fc
- Child Cost Item: 860d7f274316e99f771e5520643e7c44
- Child Cost Item: 2327bc56b32aff768d81917721176583
- Child Cost Item: 5257999040f72316c8136cde0b3fdc1f
- Child Cost Item: 431501131f77efc52634e447c0e367be
- Child Cost Item: 30df2a1049a4b780b02ee9bc958c0b41
- Child Cost Item: a934c58faf8766c9aa8346273bd2a4b3
- Child Cost Item: 0a50367f1ef75959e9a2cca385ffbc24
- Child Cost Item: 3ca7b6eba43311c046d7481601e58b63
- Child Cost Item: 7c03a8542bffa2d24aee50861756ef8f
- Child Cost Item: f98df7de2bb3e9472a85afbacc2505a2
- Child Cost Item: 41fa7ff5b462de23ef79573d0bf33699
- Child Cost Item: e4ad045ca901bd0b7792754bdb42b13b
- Child Project: MEDEVAC Mission Equipment Package (MEP) - End Dev
- Child Accomplishment: Interim MEDEVAC Mission Support System (IMMSS)